Chargement en cours...
Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study
BACKGROUND: In Malaysia, the treatment for chronic myeloid leukemia (CML) has long been delivered under the Malaysian Patient Assistance Program (MYPAP), but research on identifying factors contributing to non-adherence to tyrosine kinase inhibitors (TKIs) is still limited. The current study explore...
Enregistré dans:
| Publié dans: | Asian Pac J Cancer Prev |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
West Asia Organization for Cancer Prevention
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5648400/ https://ncbi.nlm.nih.gov/pubmed/28749622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.7.1925 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|